Average Co-Inventor Count = 4.03
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Knopp Biosciences, LLC (10 from 27 patents)
2. Knopp Neurosciences, Inc. (4 from 5 patents)
3. Areteia Therapeutics, Inc. (2 from 2 patents)
4. Biohaven Therapeutics Ltd. (1 from 28 patents)
17 patents:
1. 12370176 - Methods of use for KV7 channel activators
2. 12138249 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
3. 11612589 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
4. 11026928 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
5. 10980783 - Compositions and methods for treating conditions related to increased eosinophils
6. 10828284 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
7. 10383857 - Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils
8. 10383856 - Compositions and methods for treating conditions related to increased eosinophils
9. 10285981 - Compositions and methods for treating amyotrophic lateral sclerosis in responders
10. 9956206 - Compositions and methods for treating amyotrophic lateral sclerosis in responders
11. 9849116 - Compositions and methods of using (R)-pramipexole
12. 9662313 - Compositions and methods for treating amyotrophic lateral sclerosis in responders
13. 9468630 - Compositions and methods for treating conditions related to increased eosinophils
14. 8524695 - Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
15. 8518926 - Compositions and methods of using (R)-pramipexole